|Articles|November 1, 1999

November 1999
Volume 5
Issue 11

Developing a Managed Care Delivery System in New York State for Medicaid Recipients with HIV

Author(s)Ira Feldman, MPA, Humberto Cruz, MS, Judy DeLorenzo, MD

Download PDF: Developing a Managed Care Delivery System in New York State for Medicaid Recipients with HIV

Articles in this issue

over 26 years ago

Article

Doctor, I'm Having a Heart Attack, What Should I Do?

over 26 years ago

Article

The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation

over 26 years ago

Article

Attitudes Toward Managed Care and Cost Containment Among Primary Care Trainees at 3 Training Sites

over 26 years ago

Article

Satisfaction with Pregnancy and Newborn Care: Development and Results of a Survey in a Health Maintenance Organization

over 26 years ago

Article

The Cost of Medicaid-Covered Services Provided to Disabled Adults with Neurologic Disorders: Implications for Managed Care

over 26 years ago

Article

Estimates of Costs of Primary Care Physician Turnover

over 26 years ago

Article

Paying for HIV/AIDS Care at the Turn of the Century

over 26 years ago

Article

Developing a Managed Care Delivery System for People with HIV/AIDS

over 26 years ago

Article

Comprehensive HIV Services Under a Capitated Reimbursement System: AIDS Healthcare Foundation

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Developing a Managed Care Delivery System in New York State for Medicaid Recipients with HIV

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Innovation Is Outpacing Reimbursement, Health System Execs Warn

FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs

Remote Monitoring Captured Between-Visit Symptom Swings in Myasthenia Gravis

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer